Is Robenacoxib Superior to Meloxicam in Improving Patient Comfort in Dogs Diagnosed With a Degenerative Joint Process?

  • Adam Swallow University of Bristol

Published:

2016-01-26

Share
Open Access Logo

DOI

https://doi.org/10.18849/ve.v1i1.17

Abstract

Clinical bottom line

At normal clinical doses, there is no evidence that robenacoxib would provide superior patient comfort compared to meloxicam.

References

Schmid, V.B. et al. (2009) Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog. Journal of Veterinary Pharmacology and Therapeutics, 33 (2), pp. 118-131. http://dx.doi.org/10.1111/j.1365-2885.2009.01117.x

4,154

Save

2,523

View

Vol. 1 No. 1 (2016): The inaugural issue

Section: Knowledge Summaries

Categories :  Small Animal  /  Dogs  /  Cats  /  Rabbits  /  Production Animal  /  Cattle  /  Sheep  /  Pig  /  Equine  /  Exotics  /